ATTEMPTED PROPHYLAXIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN CHIMPANZEES WITH A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR

被引：4
|
作者：
SCHLEIF, WA
MURTHY, KK
SARDANA, VV
SCHNEIDER, CL
BYRNES, VW
COBB, KE
ROTH, E
WOLFGANG, JA
HOFFMAN, JM
SMITH, AM
GELOTTE, KM
EMINI, EA
机构：
[1] MERCK SHARP & DOHME LTD,W POINT,PA 19486
[2] SW FDN BIOMED RES,SAN ANTONIO,TX 78284
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 1994年 / 10卷 / 01期
关键词：
D O I：
10.1089/aid.1994.10.107
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：107 / 110
页数：4
相关论文
共 50 条
  • [21] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 MUTANTS RESISTANT TO NONNUCLEOSIDE INHIBITORS OF REVERSE-TRANSCRIPTASE ARISE IN TISSUE-CULTURE
    RICHMAN, D
    SHIH, CK
    LOWY, I
    ROSE, J
    PRODANOVICH, P
    GOFF, S
    GRIFFIN, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) : 11241 - 11245
  • [22] RIBAVIRIN IS AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    FERNANDEZLARSSON, R
    PATTERSON, JL
    MOLECULAR PHARMACOLOGY, 1990, 38 (06) : 766 - 770
  • [23] CHARACTERIZATION OF THE BINDING-SITE FOR NEVIRAPINE (BI-RG-587), A NONNUCLEOSIDE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    COHEN, KA
    HOPKINS, J
    INGRAHAM, RH
    PARGELLIS, C
    WU, JC
    PALLADINO, DEH
    KINKADE, P
    WARREN, TC
    ROGERS, S
    ADAMS, J
    FARINA, PR
    GROB, PM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (22) : 14670 - 14674
  • [24] INHIBITION OF REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND CHIMERIC ENZYMES OF HUMAN IMMUNODEFICIENCY VIRUSES TYPE-1 AND TYPE-2 BY 2 NOVEL NONNUCLEOSIDE INHIBITORS
    RUBINEK, T
    MCMAHON, JB
    HIZI, A
    FEBS LETTERS, 1994, 350 (2-3) : 299 - 303
  • [25] RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TO NONNUCLEOSIDE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DECLERCQ, E
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1994, 10 (04): : 145 - 158
  • [26] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITIES OF NOVEL NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS
    NOTTET, HSLM
    OTEMAN, MHT
    VISSER, MR
    VERHOEF, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (02) : 366 - 368
  • [27] COMPREHENSIVE MUTANT ENZYME AND VIRAL VARIANT ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE RESISTANCE TO NONNUCLEOSIDE INHIBITORS
    BYRNES, VW
    SARDANA, VV
    SCHLEIF, WA
    CONDRA, JH
    WATERBURY, JA
    WOLFGANG, JA
    LONG, WJ
    SCHNEIDER, CL
    SCHLABACH, AJ
    WOLANSKI, BS
    GRAHAM, DJ
    GOTLIB, L
    RHODES, A
    TITUS, DL
    ROTH, E
    BLAHY, OM
    QUINTERO, JC
    STASZEWSKI, S
    EMINI, EA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) : 1576 - 1579
  • [28] KINETIC AND MUTATIONAL ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE INHIBITION BY INOPHYLLUMS, A NOVEL CLASS OF NONNUCLEOSIDE INHIBITORS
    TAYLOR, PB
    CULP, JS
    DEBOUCK, C
    JOHNSON, RK
    PATIL, AD
    WOOLF, DJ
    BROOKS, I
    HERTZBERG, RP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (09) : 6325 - 6331
  • [29] MUTATIONAL ANALYSIS OF THE FINGERS DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BOYER, PL
    FERRIS, AL
    HUGHES, SH
    JOURNAL OF VIROLOGY, 1992, 66 (12) : 7533 - 7537
  • [30] 2 HIGHLY ANTIGENIC SITES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BJORLING, E
    BOUCHER, CAB
    SAMUELSSON, A
    WOLFS, TFW
    UTTER, G
    NORRBY, E
    CHIODI, F
    JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (03) : 588 - 592
12345